Collectively, our studies have demonstrated that cholangiocarcinoma cells, via the secretion of LAMC2, promote EMT of hepatocellular carcinoma cells, which may contribute to the poor prognosis of CHC. Here, LAMC2 is linked to hepatocellular carcinoma.